directly assessed on isolated 2 months-old CM stimulated or not with neuregulin-1 growth factor. Remarkably, while this treatment resulted in 0.17% of BrdU uptake in WT CM, it increased up to 9.57 % in KO. KO CM also exhibited significant higher mitotic (pH3+) and cytokinesis (AuroraB+) events compared to WT. Thus, the capacity for adult KO CM to proliferate is not restricted to aged CM but more likely an intrinsic potential of young KO CM. We next assessed the proliferative capacity of 2 month-old KO mice in vivo using the apectomy model. Remarkably, while WT mice developed a classical healing process (fibrosis/inflammation), KO mice almost completely regenerated the apex as indicated by the presence of mitotic (BrdU+, pH3+, AuroraB+) CM and significant reduced fibrosis (50%) in the resected zone.
The Brain Natriuretic Peptide (BNP) is a cardiac hormone, which promotes the recovery of cardiac function and the preservation of cardiac tissue in animal models of heart diseases. Its cardiac protective role in animals was attributed to fibrosis inhibition, as well as to reduction of cardiomyocyte apoptosis and hypertrophy. Recently, we demonstrated that BNP induces heart regeneration via the stimulation of cardiac precursor cell (CPC) proliferation and differentiation into mature cardiomyocytes.
The aim of our study was to identify which CPC's subset is able to respond to BNP stimulation.
Cardiac Breakthroughs in stem cell biology and demonstrations of the heart's endogenous regenerative capacities have incited an intense race towards cardiac regeneration, i.e. the replacement of lost myocardium after myocardial infarction. In preclinical trials, cell transplantation therapies, using adult human multipotent stem cells (e. g, hematopoietic stem cells) into infarcted myocardium has shown enhanced cardiogenesis in animal models. Nevertheless, results in clinical trials remain unsatisfactory and determining a suitable cell population that is easily harvested and improves cardiac repair is challenging.
In previous research, our lab isolated human peripheral blood mononuclear clones (PBMCs) bearing cardiac mesodermal markers, e.g. c-kit, Islet-1 or Flk-1. Potentially, these cells can differentiate within the cardiac lineage to mature cardiomyocytes and participate in heart repair.
We sought to establish an in vitro cardioinstructive differentiation protocol to derive cardiomyocytes from our PBMC population. For this, we screened three differentiation protocols, i.e. Keller, Smith and He protocols. To follow cell differentiation RT-qPCR and immunostainings were performed for relevant genes, e.g. Nkx2.5, GATA4, Troponin T (cTNT), β-Myosin heavy chain (β-MHC) and α-actinin. Results for mRNA expression showed that at least 75% of PBMCs can derive to a cardiac precursor population (Nkx2. Background: Cell therapy using intramyocardial injections of cardiac progenitors issued from human embryonic stem cells showed benefits on overloaded right ventricular (RV) tissue remodelling and arrhythmic susceptibility but this delivery mode failed to improve RV function. Our aim was to evaluate in a porcine model of overloaded RV dysfunction a new delivery mode of such therapy.
Methods:
A combined overloaded RV dysfunction was obtained in piglets using a surgical procedure mimicking repaired tetralogy of Fallot. After 4 months, cell therapy was surgically administrated using 2 types of human NKX2.5+ cardiac progenitor cell-seeded collagen patches applied on the epicardium: QGel® and pressured-patches. Myocardial function was measured 1 month after transplantation by conductance catheter technique and echocardiography (standard and strain). The fate of progenitors was studied using antibodies directed against Ki67, CD31, actinin and Islet1.
Results: All pigs survived without any complication. Pressured-patches allowed human progenitors to migrate across the complete myocardium while QGel® patches restricted the cell migration to only a third of the myocardium. In both cases, progenitors differentiated toward the cardiac lineage assessed by Islet1 and actinin expression and maintained their proliferation capacity. Concerning RV function, only pressured-patches (N=3) tended to improve the contractility (Emax slope). By contrast, this parameter decreased in QGel® patches animals (N=2). Moreover, in 2 pressured-patch animals, standard echocardiographic functional parameters (FAC, TAPSE, s'wave) were maintained while 2D strain and strain rate values increased.
Conclusion:
Cell therapy using seeded-patches was more conservative for engrafted cells than intramyocardial injections but only pressured-patches seemed to give benefits on overloaded RV function and contractility. These first promising results need to be checked at longer term.
